Pluri Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
/ 
Frequently asked questions
To buy Pluri Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pluri Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pluri Inc. is PLUR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pluri Inc. has its primary listing on NASDAQ. You can trade Pluri Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pluri Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pluri Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pluri Inc..